Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis

DELISTED 2026

What happened to Apellis Pharmaceuticals, Inc. (APLS) stock?

Apellis Pharmaceuticals, Inc. (APLS) no longer trades on public markets. It was delisted in May 2026. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: May 2026
Last recorded price (historical):: $41.03 (last quote on record before the May 2026 delisting; historical, not a current quote)

MCap: $5.25B| P/E Ratio: 38.71| Vol: 28.64M| Target: $62.00 (Stored FMP targets · Captured Oct 5, 2026) (estimate, not advice)| 52-wk range: $16.61 – $41.14

P/E 38.71 means the share price is 38.71 times one year of earnings per share. Market cap $5.25B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Apellis Pharmaceuticals, Inc. (APLS). Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing therapeutic compounds by inhibiting the complement system for autoimmune and and inflammatory diseases.

Last analyzed: Jun 14, 2026

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing therapeutic compounds by inhibiting the complement system for autoimmune and and inflammatory diseases. Its lead product, pegcetacoplan, is in Phase III trials for geographic atrophy and paroxysmal nocturnal hemoglobinuria, alongside other pipeline assets.

These figures come from statements filed 13 months ago — the most recent this company has published.

Apellis Pharmaceuticals, Inc. (APLS) Healthcare & Pipeline Overview

Employees705

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 74% (not a measure of the evidence) Updated: Jun 14, 2026

More about this archive record

Can I still buy APLS shares?

No. APLS stopped trading on public markets in May 2026, so the shares are not available through a broker. Anything you see quoted for APLS elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before APLS stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Apellis Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Jun 14, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Jun 14, 2026.

Data provided for informational purposes only.